{'fraction_non_alphanumeric': 0.017326732673267328, 'fraction_numerical': 0.0049504950495049506, 'mean_word_length': 5.38421052631579, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.

ABSTRACT Familial dwarfism with high plasma IR-HGH is a syndrome which is clinically indistinguishable from hereditary monotropic dwarfism due to lack of growth hormone (HGH) secretion. Furthermore, in both types of dwarfism there is a spontaneous hypoglycemia, hypoglycemia nonresponsiveness after the injection of insulin, and a reduced insulin response after arginine infusion. The metabolic and linear growth response to exogenous HGH was studied in 16 patients with this syndrome and compared to that in 19 patients with pituitary dwarfism due to HGH deficiency (isolated or concomitant with other hormones), as well as in 4 newborns and a patient with active acromegaly who had elevated concentrations of HGH in the plasma. A number of important differences in response were observed. After intravenous HGH administration, patients with familial dwarfism and high HGH had a smaller rise in plasma FFA than occurred in true pituitary dwarfs. Administration of HGH intramuscularly for 4 days induced no rise in plasm...